| |
|
|
|
Corbus Pharma  
|
|
1.22 0 (0%) |
11-30 14:31 |
|
Open: |
1.25 |
Pre close: |
1.22 |
Target:
|
1.55
|
|
High: |
1.27 |
Low: |
1.22 |
Resistance:
|
1.32
1.58
|
|
Volume: |
2,493,301 |
Market Cap: |
103M |
Support:
|
0.91
0.76
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.22
 |
MACD |
MACD(12,26):
|
-0.07 |
|
MA(20): |
1.20 |
Signal(12,26,9): |
-0.11 |
|
MA(100): |
3.88  |
Stochastic Oscillator |
%K(14,3):
|
31.95 |
|
MA(250): |
5.23 |
%D(3): |
33.79 |
|
Average Volume(K) |
3-Month: |
583590
|
52-Week |
High:
|
9.78 |
|
10-Days: |
278286 |
Low: |
0.91 |
|
RSI |
RSI(14):
|
43.89 |
Change(%): |
-74.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.784 |
Return on Equity (ttm) |
-439.1 |
Shares Out. (M) |
84.04 |
|
EPS Est. Current Year |
-0.640 |
Return on Assets (ttm) |
-98.5 |
Shares Float (M) |
75.35 |
|
EPS Est. Next Year |
-0.680 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.73 |
|
EPS Est. Next Quarter |
-0.180 |
Qtrly Rev. Growth |
-52.5 |
% Held by Institutions |
73.52 |
|
Forward EPS |
-1.120 |
Gross Profit (p.s.) |
-0.636 |
Shares Short (K) |
37470 |
|
Book Value (p.s.) |
0.360 |
EBITDA (p.s.) |
-1.524 |
P/E |
-0.68 |
|
Sales Per Share |
0.070 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.39 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-104.02 |
P/S |
17.53 |
|
Operating Margin |
-2207.39 |
Levered Free Cash Flow
(M) |
-58.40 |
P/CF |
-0.99 |
|
|
|
|
|
|
